Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Seer (SEER)
NASDAQ:SEER
Holding SEER?
Track your performance easily
SEER Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.46 - $2.46
Previous Close$2.24
Volume264.21K
Average Volume (3M)291.44K
Market Cap
$132.09M
Enterprise Value-$89.02M
Total Cash (Recent Filing)$247.60M
Total Debt (Recent Filing)$26.50M
Price to Earnings (P/E)―
Beta2.31
Next Earnings
Feb 27, 2025EPS Estimate
-$0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.30
Shares Outstanding58,966,560
10 Day Avg. Volume292,206
30 Day Avg. Volume291,440
Standard Deviation0.19
R-Squared0.13
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)0.39
Price to Sales (P/S)9.26
Price to Cash Flow (P/CF)-2.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-6.20
Enterprise Value/Gross Profit-12.67
Enterprise Value/Ebitda1.14
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
Seer News
PremiumCompany Announcements
Seer, Inc. Reports Q3 2024 Financial Results
PremiumCompany Announcements
Seer, Inc. Appoints Dr. Nicolas Roelofs to Board of Directors
Bulls Say, Bears Say
Bulls Say
Financial PerformanceService revenue grew +46% year-over-year to $682K and came in ahead of expectations.
Market MomentumInterest in Proteograph has gained momentum following the publication of several third-party studies supporting the use of the platform.
Strategic PartnershipsSEER signed an agreement with TMO to co-market Proteograph with TMO's Astral, which can represent a meaningful future demand driver.
Bears Say
2024 Revenue GuidanceGuidance for 2024 revenue was reduced to account for a weaker outlook in the latter half, reflecting ongoing challenges in the macroeconomic environment.
Product Revenue ShortfallProduct revenue fell short of projections as management faced ongoing pressure on capital expenditure budgets and extended sales cycles for instrument purchases.
Revenue DeclineTotal revenue of approximately $3.1 million experienced a year-over-year decrease of 23%, coming in below expectations due to reduced related party revenue.
---
Ownership Overview
7.32% Insiders
12.24% Mutual Funds
2.07% Other Institutional Investors
73.57% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SEER FAQ
What was Seer’s price range in the past 12 months?
Seer lowest stock price was $1.46 and its highest was $2.46 in the past 12 months.
What is Seer’s market cap?
Currently, no data Available
When is Seer’s upcoming earnings report date?
Seer’s upcoming earnings report date is Feb 27, 2025 which is in 99 days.
How were Seer’s earnings last quarter?
Seer released its earnings results on Nov 06, 2024. The company reported -$0.35 earnings per share for the quarter, missing the consensus estimate of -$0.308 by -$0.042.
Is Seer overvalued?
According to Wall Street analysts Seer’s price is currently Overvalued.
Does Seer pay dividends?
Seer does not currently pay dividends.
What is Seer’s EPS estimate?
Seer’s EPS estimate is -$0.37.
How many shares outstanding does Seer have?
Seer has 54,921,593 shares outstanding.
What happened to Seer’s price movement after its last earnings report?
Seer reported an EPS of -$0.35 in its last earnings report, missing expectations of -$0.308. Following the earnings report the stock price went up 7.246%.
Which hedge fund is a major shareholder of Seer?
Among the largest hedge funds holding Seer’s share is Wexford Capital LP. It holds Seer’s shares valued at N/A.
---
Seer Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
― (―)
― (―)
Hedge Fund Trend
Decreased
By 274.9K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
43.58%
12-Months-Change
Fundamentals
Return on Equity
-22.03%
Trailing 12-Months
Asset Growth
-13.81%
Trailing 12-Months
Company Description
Seer
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across the proteome.
---
SEER Earnings Call
Q3 2024
0:00 / 0:00
---
SEER Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering SEER
1 Year
1 Year Success Rate
4/5 ratings generated profit
1 Year Average Return
+0.50%
assigned a buy rating 14 days ago
Copying Daniel Brennan's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +0.50% per trade.
---